Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial.

Saved in:
Bibliographic Details
Title: Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial.
Authors: Daley-Yates P; Respiratory Clinical Development, GSK Research and Development, Stockley Park West, 1-3 Ironbridge Road, Uxbridge, Middlesex, UB11 1BT, UK. Peter.T.Daley-Yates@gsk.com., Keppler B; Metabolon Inc., 617 Davis Drive, Suite 100, Morrisville, NC, 27560, USA., Baines A; Medicines Development Centre, GSK Research and Development, Stevenage, UK., Bardsley G; Tauranga Hospital, 829 Cameron Road, Tauranga South, Tauranga, 3112, New Zealand., Fingleton J; Medical Research Institute of New Zealand, Wellington, New Zealand.
Source: Respiratory research [Respir Res] 2022 Sep 20; Vol. 23 (1), pp. 258. Date of Electronic Publication: 2022 Sep 20.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36127726
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Daley-Yates+P%22">Daley-Yates P</searchLink>; Respiratory Clinical Development, GSK Research and Development, Stockley Park West, 1-3 Ironbridge Road, Uxbridge, Middlesex, UB11 1BT, UK. Peter.T.Daley-Yates@gsk.com.<br /><searchLink fieldCode="AU" term="%22Keppler+B%22">Keppler B</searchLink>; Metabolon Inc., 617 Davis Drive, Suite 100, Morrisville, NC, 27560, USA.<br /><searchLink fieldCode="AU" term="%22Baines+A%22">Baines A</searchLink>; Medicines Development Centre, GSK Research and Development, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Bardsley+G%22">Bardsley G</searchLink>; Tauranga Hospital, 829 Cameron Road, Tauranga South, Tauranga, 3112, New Zealand.<br /><searchLink fieldCode="AU" term="%22Fingleton+J%22">Fingleton J</searchLink>; Medical Research Institute of New Zealand, Wellington, New Zealand.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101090633%22">Respiratory research</searchLink> [Respir Res] 2022 Sep 20; Vol. 23 (1), pp. 258. <i>Date of Electronic Publication: </i>2022 Sep 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central+Ltd%22">BioMed Central Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101090633 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1465-993X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214659921%22">14659921 </searchLink><i>NLM ISO Abbreviation: </i>Respir Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36127726
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12931-022-02164-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 258
    Titles:
      – TitleFull: Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Daley-Yates P
      – PersonEntity:
          Name:
            NameFull: Keppler B
      – PersonEntity:
          Name:
            NameFull: Baines A
      – PersonEntity:
          Name:
            NameFull: Bardsley G
      – PersonEntity:
          Name:
            NameFull: Fingleton J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 09
              Text: 2022 Sep 20
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1465-993X
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Respiratory research
              Type: main
ResultId 1